In a blog post today, APA CEO and Medical Director Saul Levin, M.D., M.P.A., marked the 25th anniver...

The Food and Drug Administration on Monday approved Aristada (aripiprazole lauroxil), a long-acting ...

The use of second-generation antipsychotics (SGAs) during the first trimester does not appear to sub...

Youth with attention-deficit/hyperactivity disorder (ADHD) and congenital heart disease may be able ...

In a blog post today, APA President Renée Binder, M.D., called for the implementation of “common sen...

America’s latest mass shooting prompted a quick response from the Oregon Psychiatric Physicians Asso...

Even as the excitement over the potential of ketamine and other NMDA receptor antagonists for antide...

Adding a low dose of the antipsychotic aripiprazole to the antidepressant regimen of older adults wi...

A tool to help patients with depression make informed decisions about appropriate antidepressants im...